to treat and help protect from a VTE—both inpatient and outpatient*1-7 XARELTO® VTE Platform
at Day 10 and Day 35 vs standard of care in acutely ill medical patients in the MAGELLAN subgroup Efficacy Profile
◇For VTE prophylaxis in acutely ill medical patients at risk for thromboembolic complications who are not at high risk of bleeding.
*The decision regarding initiation setting should be based on the prescriber's clinical judgment.
VTE = venous thromboembolism.